Related Experiment Video
Updated: Aug 15, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench
Mohga El-Abbadi1, Cecilia M Giachelli
1Bioengineering Department, University of Washington, Seattle, Washington 98195, USA.
Insights
Vascular calcification, linked to mineral metabolism disturbances in chronic kidney disease patients, significantly lowers survival rates. Understanding these processes is key to developing new treatments for this condition.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Mineral Metabolism
Background:
- Cardiovascular disease is the primary cause of death in chronic kidney disease (CKD) patients.
- Mineral metabolism disturbances, particularly elevated calcium and phosphate, are implicated in CKD-related cardiovascular complications.
- Vascular and valvular calcification are significant contributors to poor prognosis in CKD.
Purpose of the Study:
- To review recent findings on the etiology of vascular calcification.
- To emphasize pathways relevant to vascular calcification in CKD patients.
- To highlight the link between mineral metabolism and cardiovascular risk in CKD.
Main Methods:
- Literature review of recent studies on vascular calcification.
- Analysis of etiological factors and regulatory pathways.
- Focus on chronic kidney disease patient populations.
Main Results:
- Both intimal and medial vascular calcification correlate with reduced survival in CKD patients.
- Vascular calcification is an actively regulated process with identified inducers (calcium, phosphate, inflammatory cytokines) and inhibitors (matrix Gla protein, fetuin, pyrophosphate, osteopontin).
- These factors contribute to the high prevalence of vascular calcification in CKD.
Conclusions:
- Vascular calcification is a significant factor in decreased survival among CKD patients.
- Understanding the regulatory mechanisms of vascular calcification is crucial for therapeutic development.
- Novel therapeutics may be developed to manage or reverse vascular calcification in CKD.
Purpose Of Review:
Cardiovascular disease is the leading cause of death in patients with chronic kidney disease. A growing body of data points to nontraditional risk factors, including disturbances in mineral metabolism, as important determinants of the extremely high cardiovascular morbidity and mortality rates in these patients. Disturbances in mineral metabolism, especially elevated calcium and phosphate levels, have been linked to vascular and valvular calcification, both of which are associated with poor prognosis in chronic kidney disease patients. This review highlights important recent findings regarding the etiology of vascular calcification, with special emphasis on pathways that may be particularly relevant in chronic kidney disease patients.
Recent Findings:
New studies indicate that not only vascular intimal calcification (associated with atherosclerosis) but also vascular medial calcification are correlated with decreased survival in chronic kidney disease patients. With the relatively recent recognition of vascular calcification as an actively regulated process, a growing list of inducers (calcium, phosphate, inflammatory cytokines) and inhibitors (matrix Gla protein, fetuin, pyrophosphate, osteopontin) have been discovered. Interesting recent evidence suggests that they may contribute to the prevalence of this pathology in chronic kidney disease patients.
Summary:
Vascular calcification is associated with decreased survival in chronic kidney disease patients. Understanding the causes and regulatory factors controlling vascular calcification will help refine therapeutic modalities currently in use, as well as develop novel therapeutics to abate and potentially reverse this deleterious process.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Atherosclerosis I: Introduction
Chronic Kidney Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction

